Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowOctober 03, 2025 — 3:45 PM - 4:15 PM ET
Nasdaq MarketSite, 4 Times Square, New York
BridgeBio Oncology Therapeutics (BBOT) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Eli Wallace, PhD, CEO, rings the Closing Bell.
